Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical hyperthermia and chemotherapy.

F K Storm1

  • 1Division of Surgical Oncology, University of Wisconsin Medical School, Madison.

Radiologic Clinics of North America
|May 1, 1989
PubMed
Summary

Hyperthermia enhances chemotherapy effectiveness, especially when combined with drugs at 40-43°C. Loco-regional hyperthermia shows promise for advanced diseases with improved responses and no increased toxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of frozen section analysis of margins during breast conservation surgery.

The cancer journal from Scientific American·1997
Same author

Heat shock protein 27 stimulates recovery of RNA and protein synthesis following a heat shock.

Journal of cellular biochemistry·1997
Same author

Heat shock protein 27 overexpression in breast cancer lymph node metastasis.

Annals of surgical oncology·1996
Same author

Lack of association between tumor necrosis and hsp-27 expression in primary breast cancer.

Journal of surgical oncology·1996
Same author

Interleukin-2 does not sequester activated lymphocytes into lung lymph of sheep.

The Journal of surgical research·1996
Same author

Re: "Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989".

American journal of epidemiology·1995

Area of Science:

  • Oncology
  • Medical Physics
  • Pharmacology

Background:

  • Hyperthermia can enhance chemotherapy efficacy through additive or synergistic effects.
  • Drug response to hyperthermia varies with temperature, with some drugs effective at 39°C and others requiring 42-43°C.

Purpose of the Study:

  • To investigate the additive and synergistic effects of hyperthermia with various chemotherapeutic agents.
  • To evaluate the clinical utility and toxicity of hyperthermia combined with chemotherapy.

Main Methods:

  • In vitro and in vivo studies assessing drug-heat interactions.
  • Clinical trials using whole-body hyperthermia (WBH) and regional perfusion with hyperthermia.
  • Analysis of response rates and toxicity in relation to thermal dose and drug administration route (IV/IA).

Main Results:

  • Synergistic effects observed in vivo with multiple chemotherapeutic agents (e.g., methotrexate, cisplatin, doxorubicin).
  • Optimal enhancement achieved when heat and chemotherapy are administered simultaneously.
  • Localized hyperthermia with chemotherapy demonstrated objective responses in approximately one-third of patients without increased drug toxicity.
  • Responses are thermal-dose dependent, with maximum enhancement between 40-43°C.

Conclusions:

  • Loco-regional hyperthermia combined with chemotherapy is a viable treatment option, potentially improving outcomes in advanced diseases.
  • Hyperthermia does not appear to increase chemotherapy toxicity when applied locally.
  • Further research is needed to optimize thermochemotherapy protocols and drug-heat interactions.

Related Experiment Videos